Google plans to release new ‘open AI models for drug discovery

During an incident in New York on Tuesday, Google has developed a collection of “Open” ai models for a drug called TXGemma.

Google’s AI models will be released through it Health AI Developer Foundations The program may understand the structures of different “therapeutic institutions”, including chemicals, molecules and proteins, including both the end of this month, chemicals, molecules and proteins.

“The development of therapeutic drugs to the approved use of therapeutic drugs is a long and expensive process, so we will work with a wider research community, the new ways to be more efficient,” Karen Desalvo wrote in a blog post provided to TechCrunch. “(R) Esearchers can ask TXGemma questions to help predict important features of potential new treatment as safe or important features.”

Google did not say that the license of the models was allowed for commercial use, customization or delicate arrangement. TechCrunch has reached the company for more information and updates if the company responds.

Google Spin-Out, including countless companies Isomorf LaboratoriesEU’s earliest R & D steps acting sharply and promised to revolutionize the discovery of a day. Although there are some success, the AI ​​lab did not provide a magical solution immediately.

A few companies using the AI ​​for drug detection including Excientia and BenevolentaiThey have suffered High profile Clinical trial failures in recent years. Meanwhile, as Google Deepmind, the accuracy of the leading AI systems for drug discovery Alphafold 3, tends to change widespread.

Again, Big Pharma – and investors look enthusiastic to the potential of Tech. In January, Pharma giants said Isomorphic, which was a partnership with Eli Lilly and Novartis, said that this year was waiting for the test of processed drugs this year. Suddenly estimateMore than 460 AI starting medicinal discovery and Investors poured 60 billion dollars in space so far.